AdvancedAdvT beats FY26 forecasts with over 27% EBITDA margins and 80% recurring revenue. Steady execution delivers growth and optionality.
This article covers information on AdvancedAdvT Limited.
LON:ADVTAdvancedAdvT Limited (AIM: ADVT) has posted a pre-close trading update for the year ending 28 February 2026, and it’s a tidy step ahead of market expectations. Revenue and adjusted EBITDA both beat consensus, margins have nudged higher again, and recurring revenue remains the bedrock of the model.
For retail investors, the message is simple: steady execution, better-than-expected profitability, and a sizeable cash pile that keeps options open.
| Metric | FY26 (pre-close) | FY25 | Market consensus (FY26) |
|---|---|---|---|
| Revenue | Approximately £53.0 million | £43.3 million | Approximately £52.5 million |
| Adjusted EBITDA | Not less than £14.4 million | £11.3 million | Approximately £13.7 million |
| Adjusted EBITDA margin | Over 27% | 26% | Not disclosed |
| Recurring revenue mix | Approximately 80% | Not disclosed | Not applicable |
| Cash balance (28 Feb 2026) | Approximately £96.0 million | Not disclosed | Approximately £96.0 million |
| Investments during the year | Circa £15.0 million | Not disclosed | Not applicable |
That revenue implies roughly 22% year-on-year growth, with adjusted EBITDA up by at least around 27%. The beat versus consensus is modest on revenue (about £0.5 million) and more meaningful on EBITDA (at least £0.7 million), which underscores the margin work flowing through.
AdvancedAdvT reports approximately 80% of revenue as recurring. In plain English, that’s contracted or subscription-like income that rolls in each period, offering visibility and stability. The update also flags “excellent customer retention” across both divisions, which supports low churn and strengthens lifetime value. Exact retention metrics are not disclosed, but the language and the 80% mix point to a sticky customer base.
Adjusted EBITDA margins are now over 27%, up from 26% last year and approximately 21% in the Group’s first reporting period. That’s a clear trend of operational tightening and scale benefits. Adjusted EBITDA refers to earnings before interest, tax, depreciation and amortisation, adjusted for items management considers non-recurring or non-core. It’s a common profitability measure in software, and this steady climb suggests the portfolio is being tuned effectively.
The Group’s software sits in two transformation lanes: business solutions and healthcare compliance, and human capital management (HCM). These are regulated, mission-critical workflows where switching can be painful for customers and reliability matters. That positioning helps explain the recurring mix and retention strength.
Related
Polar Capital Technology Trust sees 102% NAV growth in FY2026, beating its benchmark by 47 points thanks to AI and semiconductor exposure.
JoshuaJuly 10, 2026
Last updated
Category
InvestingViews
34 viewsLikes
No ratings yet
Executive Chair Vin Murria is clear on the role of AI here: in AdvancedAdvT’s markets, AI “acts as an amplifier” of platform value rather than a threat. In practice, that means productivity gains for customers, a potentially larger addressable market, and greater importance on trusted, compliant software. It also fits the company’s stated capability set around AI, data analytics and business intelligence.
My take: that’s a sensible framing for software embedded in regulated, workflow-heavy environments. The risk of disruption never fully disappears, but with systems of record that are deeply integrated, the balance of probabilities tilts toward enhancement rather than displacement.
Cash is expected to be approximately £96 million at year-end, in line with market expectations. The Group also notes circa £15 million of investments during the year. The update doesn’t break down what those investments comprise, and there’s no comment on net cash or debt positions – not disclosed.
Strategically, the note to editors reiterates that AdvancedAdvT is developing both organically and through acquisitions, expanding across adjacent markets and geographies. With this cash balance, the company has room to invest in product, tuck-in deals, or both, subject to discipline and returns.
On the flip side, there are a few watchpoints. The company hasn’t disclosed segmental revenue, net cash, or detailed outlook metrics in this update. The size and nature of the circa £15 million investments are also not specified. For a fuller picture, the audited results and narrative will matter.
The RNS does not specify the date for the full-year results publication.
This is a tidy pre-close from AdvancedAdvT. Revenue growth of approximately 22%, margin progress to over 27%, and an EBITDA beat suggest the operating playbook is working. The “systems of record” positioning in regulated, mission-critical workflows naturally lends itself to sticky, recurring income – and that’s exactly what the numbers reflect.
With approximately £96 million of cash and a stated appetite for organic and acquisitive growth, the company has options. The next set of audited numbers should fill in the blanks on divisional performance, retention metrics and capital allocation. For now, the direction of travel is positive, and the business looks well placed to keep compounding through operational improvements and disciplined execution.
Impax Q3 AUM rises to £23.3bn despite £1.7bn net outflows, driven by market gains and strong investment performance.
JoshuaJuly 10, 2026
MJ Gleeson FY2026 trading update: steady profits, mixed home sales with operational restructuring improving outlook.
JoshuaJuly 10, 2026
No comments yet - start the conversation.